PharmaSource: The External Manufacturing Community

Your Biopharma Outsourcing Intelligence Hub

Trusted by 50,000+ biopharma manufacturing professionals Sign up for Newsletter

FDA Scrutiny Is Exposing a CDMO Quality Oversight Crisis

AmbioPharm Invests $118.96 Million in South Carolina Peptide Manufacturing Expansion

Mabion Extends Novavax Manufacturing Agreement Through 2029

SK pharmteco Partners With OTXL to Advance Rare Disease Therapies

Matica Bio Launches Korea IIT Platform for Cell and Gene Therapy Development

MilliporeSigma and KBI Biopharma Partner on Integrated ADC Development Services

Minaris Enhances GMP Cell Banking Suites at Philadelphia Facility

Alcami Invests in Tennessee Facility Following Tjoapack Acquisition

Resilience Relocates Corporate Headquarters from California to Ohio

WuXi Biologics Secures Fourth EMA GMP Certification for Suzhou Facility

Sandoz Opens USD 99 Million Biosimilar Development Centre in Slovenia

AmbioPharm Invests $118.96 Million in South Carolina Peptide Manufacturing Expansion

Mabion Extends Novavax Manufacturing Agreement Through 2029

SK pharmteco Partners With OTXL to Advance Rare Disease Therapies

PODCASTS

Simtra BioPharma CCO: “Manufacturing in the Region for the Region Is Here to Stay”

Closing the Valley of Death: The Infrastructure Gap Holding Back Early-Stage Biologics Programs

SPOTLIGHT

Why Compliance-Driven CDMOs Win Sponsor Contracts

RESOURCES

Resilience, Risk & Relationships – ExM Leaders Report

[DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report

Resilience, Risk & Relationships – ExM Leaders Report

UPCOMING EVENTS

External Manufacturing Leaders Basel 2026

CDMO Live Europe 2027

CDMO Live Americas 2026

PharmaSource: The External Manufacturing Community

FDA Scrutiny Is Exposing a CDMO Quality Oversight Crisis

FDA Scrutiny Is Exposing a CDMO Quality Oversight Crisis

AmbioPharm Invests $118.96 Million in South Carolina Peptide Manufacturing Expansion

Mabion Extends Novavax Manufacturing Agreement Through 2029

SK pharmteco Partners With OTXL to Advance Rare Disease Therapies

Matica Bio Launches Korea IIT Platform for Cell and Gene Therapy Development

MilliporeSigma and KBI Biopharma Partner on Integrated ADC Development Services

Minaris Enhances GMP Cell Banking Suites at Philadelphia Facility

Alcami Invests in Tennessee Facility Following Tjoapack Acquisition

Resilience Relocates Corporate Headquarters from California to Ohio

WuXi Biologics Secures Fourth EMA GMP Certification for Suzhou Facility

Sandoz Opens USD 99 Million Biosimilar Development Centre in Slovenia

AmbioPharm Invests $118.96 Million in South Carolina Peptide Manufacturing Expansion

Mabion Extends Novavax Manufacturing Agreement Through 2029

SK pharmteco Partners With OTXL to Advance Rare Disease Therapies

Simtra BioPharma CCO: “Manufacturing in the Region for the Region Is Here to Stay”

Closing the Valley of Death: The Infrastructure Gap Holding Back Early-Stage Biologics Programs

Why Compliance-Driven CDMOs Win Sponsor Contracts

Resilience, Risk & Relationships – ExM Leaders Report

[DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report

Resilience, Risk & Relationships – ExM Leaders Report

External Manufacturing Leaders Basel 2026

CDMO Live Europe 2027

CDMO Live Americas 2026

Welcome to PharmaSource

Follow us

Top Links

Get in touch